Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Follows people with early spondyloarthritis and related conditions in Germany over time

Follows people with early spine-related arthritis and linked conditions over several years.

Key facts

Who runs it
Charite University, Berlin, Germany
Where
Berlin, GermanySee the site
Trial code
Registry title
German Spondyloarthritis Inception Cohort
Status
Recruiting
People taking part
1,000 people, planned
Started
Jul 2000
Expected to end
Jul 2030
Type of study
Observational, 6 groups
Record updated
12 October 2021

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with a definite diagnosis of axial spondyloarthritis, juvenile spondyloarthritis, Crohn's disease, acute anterior uveitis, or psoriatic arthritis with axial involvement.

Sex
All sexes can join.
Disease stage
A definite diagnosis of axial spondyloarthritis or juvenile spondyloarthritis, Crohn's disease, acute anterior uveitis, or psoriatic arthritis with axial involvement.

The registry criteria, word for word

Show all 5 criteriaShow less

Other criteria

  • Main inclusion Criteria:
  • Patients with definite diagnosis of axial spondyloarthritis or juvenile spondyloarthritis
  • Patients with definite diagnosis of Crohn's disease
  • Patients with definite diagnosis of acute anterior uveitis
  • Patients with definite diagnosis of psoriatic arthritis with axial involvement

Where in Germany

  • Charité Universitätsmedizin BerlinBerlin, GermanyContact: Claudia LorenzTaking people

About the trial

What the trial wants to find out

The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis (AS, also known as radiographic axial spondyloarthritis) and non-radiographic axial SpA. The objectives of GESPIC are to learn about the course of SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs). GESPIC has been recently expanded to recruit patients with other forms of SpA / conditions associated with SpA: acute anterior uveitis, Crohn's disease as well as with psoriasis / axial psoriatic arthritis.

The 6 groups in the trial

  • Ankylosing spondylitis

    Ankylosing spondylitis according to the modified New York criteria or with the clinical diagnosis of AS/r-axSpA fulfilling the ASAS Classification Criteria AND the mNY criteria plus having the indiaction for starting a bDMARD therapy according to the treating rheumatologist

  • Non-radiographic axial spondyloarthritis

    Patients with clinical characteristics of axial SpA but not fulfilling the modified New York criteria for which radiographic sacroiliitis is essential or with the clinical diagnosis of nr-axSpA fulfilling the ASAS Classification Criteria not fulfilling the mNY criteria and the indiaction for starting a bDMARD therapy according to the treating rheumatologist

  • Juvenile spondyloarthritis

    Patients with juvenile spondyloarthritis (juvenile ankylosing spondylitis, juvenile non-AS-spondyloarthritis).

  • Crohn's disease

    Patients with Crohn's disease

  • Acute anterior uveitis

    Patients with acute anterior uveitis

  • Axial psoriatic arthritis

    Patients with the clinical diagnosis of psoriatic arthritis with axial involvement (sacroiliac joints and/or spine) (axPsA)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
German Spondyloarthritis Inception Cohort
Plain-language title
Follows people with early spondyloarthritis and related conditions in Germany over timeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
12 October 2021